Ignite Creation Date:
2024-05-05 @ 11:42 PM
Last Modification Date:
2024-10-26 @ 10:38 AM
Study NCT ID:
NCT01399593
Status:
TERMINATED
Last Update Posted:
2017-10-03
First Post:
2011-07-19
Brief Title:
Safety Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization
Sponsor:
Alexion Pharmaceuticals Inc
Organization:
Alexion Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-11-02
Start Date Type:
ACTUAL
Primary Completion Date:
2014-05-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-11-13
Completion Date Type:
ACTUAL
First Submit Date:
2011-07-19
First Submit QC Date:
July 20 2011
Study First Post Date:
2011-07-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2017-04-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2016-11-18
Disp First Submit QC Date:
November 18 2016
Disp First Post Date:
2016-11-21
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-09-04
Last Update Post Date:
2017-10-03
Last Update Post Date Type:
ACTUAL